Susquehanna International Group’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-50,683
Closed -$2.41M 12233
2025
Q3
$2.41M Sell
50,683
-157,071
-76% -$7.61M ﹤0.01% 5399
2025
Q2
$11.1M Buy
207,754
+27,364
+15% +$1.24M 0.02% 2693
2025
Q1
$7.3M Buy
180,390
+145,122
+411% +$6.15M 0.01% 2969
2024
Q4
$981K Buy
35,268
+13,767
+64% +$417K ﹤0.01% 6990
2024
Q3
$617K Sell
21,501
-13,936
-39% -$363K ﹤0.01% 7968
2024
Q2
$831K Sell
35,437
-68,683
-66% -$1.47M ﹤0.01% 7024
2024
Q1
$2.63M Buy
104,120
+82,403
+379% +$1.98M ﹤0.01% 4767
2023
Q4
$507K Sell
21,717
-329,192
-94% -$6.49M ﹤0.01% 8632
2023
Q3
$17.7M Buy
350,909
+256,446
+271% +$11.9M 0.03% 1865
2023
Q2
$4.41M Sell
94,463
-4,240
-4% -$194K 0.01% 3738
2023
Q1
$3.78M Buy
98,703
+63,149
+178% +$2.82M 0.01% 3884
2022
Q4
$1.95M Sell
35,554
-37,423
-51% -$1.6M ﹤0.01% 4747
2022
Q3
$2.48M Buy
+72,977
New +$1.12M 0.01% 4475
2022
Q2
Sell
-27,553
Closed -$287K 12803
2022
Q1
$391K Sell
27,553
-28,841
-51% -$505K ﹤0.01% 9593
2021
Q4
$1.19M Buy
56,394
+5,648
+11% +$125K ﹤0.01% 6820
2021
Q3
$1.13M Sell
50,746
-24,614
-33% -$557K ﹤0.01% 7235
2021
Q2
$1.87M Sell
75,360
-147,765
-66% -$4.15M ﹤0.01% 6067
2021
Q1
$6.47M Buy
223,125
+208,854
+1,463% +$6.32M 0.01% 3447
2020
Q4
$368K Sell
14,271
-8,823
-38% -$245K ﹤0.01% 8881
2020
Q3
$711K Sell
23,094
-5,093
-18% -$178K ﹤0.01% 6929
2020
Q2
$702K Sell
28,187
-1,707
-6% -$39K ﹤0.01% 6655
2020
Q1
$634K Buy
+29,894
New +$641K ﹤0.01% 6410

Other funds holding AKRO